清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Hypertonic saline use in neurocritical care for treating cerebral edema: A review of optimal formulation, dosing, safety, administration and storage

医学 神经重症监护 高渗盐水 加药 重症监护医学 脑水肿 麻醉 脑水肿 生理盐水 药理学
作者
Devin Holden,Jeffrey Mucksavage,John A Cokley,Keri S. Kim,Natalie Tucker,Molly S Esordi,Aaron M. Cook
出处
期刊:American Journal of Health-system Pharmacy [Oxford University Press]
卷期号:80 (6): 331-342 被引量:14
标识
DOI:10.1093/ajhp/zxac368
摘要

Abstract Purpose Current Neurocritical Care Society guidelines on the management of cerebral edema recommend hypertonic saline (HTS) over mannitol in some scenarios, but practical questions remain regarding the appropriate administration method, concentration/dose, monitoring to ensure safe use, and storage. The aim of this article is to address these practical concerns based on the evidence currently available. Summary Many different hypertonic solutions have been studied to define the optimal hyperosmolar substance to relieve acute cerebral edema in patients with conditions such as acute ischemic stroke, intracerebral hemorrhage, subarachnoid hemorrhage, and traumatic brain injury. Mannitol and HTS are the main hyperosmolar therapies in use in contemporary neurocritical care practice. Contemporary use of HTS has followed a circuitous path in regards to the practical aspects of dosing and formulation, with evidence mainly consisting of retrospective or observational data. The effectiveness of bolus doses of HTS to lower acutely elevated intracranial pressure is well accepted. Adverse events with use of HTS are often mild and non–clinically significant if appropriate monitoring of serum sodium and chloride concentrations is performed. Available evidence shows that peripheral administration of HTS is likely safe in certain circumstances. Timely utilization of HTS is complicated by regulatory requirements for safe storage, but with appropriate safeguards HTS can be stored in patient care areas. Conclusion HTS formulations, methods of administration, infusion rate, and storage vary by institution, and no practice standards exist. Central intravenous administration may be preferred for HTS, but peripheral intravenous administration is safe provided measures are undertaken to detect and prevent phlebitis and extravasation. The safe use of HTS is possible with proper protocols, education, and institutional safeguards in place.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
9秒前
小爱应助gjn采纳,获得10
13秒前
24秒前
gjn完成签到,获得积分10
30秒前
爱听歌依波完成签到 ,获得积分10
43秒前
沙海沉戈完成签到,获得积分0
1分钟前
小鸭嘎嘎完成签到 ,获得积分10
1分钟前
Criminology34应助科研通管家采纳,获得10
1分钟前
Criminology34应助科研通管家采纳,获得10
1分钟前
爆米花应助科研通管家采纳,获得10
1分钟前
Criminology34应助科研通管家采纳,获得10
1分钟前
科研通AI2S应助科研通管家采纳,获得10
1分钟前
Ray完成签到 ,获得积分10
1分钟前
1分钟前
千空完成签到 ,获得积分10
1分钟前
萌兴完成签到 ,获得积分10
1分钟前
lingling完成签到 ,获得积分10
2分钟前
和谐的青筠完成签到,获得积分10
2分钟前
2分钟前
ccc发布了新的文献求助10
2分钟前
万能图书馆应助ccc采纳,获得10
2分钟前
ccc完成签到,获得积分20
2分钟前
现代的严青完成签到 ,获得积分10
2分钟前
跳跃豆芽完成签到 ,获得积分10
3分钟前
研友_LN25rL完成签到,获得积分10
3分钟前
CipherSage应助阿米尔盼盼采纳,获得10
3分钟前
Criminology34应助科研通管家采纳,获得10
3分钟前
Criminology34应助科研通管家采纳,获得20
3分钟前
科研通AI2S应助科研通管家采纳,获得10
3分钟前
Criminology34应助科研通管家采纳,获得20
3分钟前
binfo完成签到,获得积分0
3分钟前
YZY完成签到 ,获得积分10
3分钟前
爱在深秋完成签到,获得积分10
4分钟前
我很厉害的1q完成签到,获得积分10
4分钟前
4分钟前
游泳池完成签到,获得积分10
4分钟前
lwj发布了新的文献求助10
4分钟前
qianzhihe2完成签到,获得积分10
4分钟前
科多兽骑士完成签到 ,获得积分10
4分钟前
王世卉完成签到,获得积分10
5分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Kinesiophobia : a new view of chronic pain behavior 2000
Research for Social Workers 1000
Mastering New Drug Applications: A Step-by-Step Guide (Mastering the FDA Approval Process Book 1) 800
Signals, Systems, and Signal Processing 510
Discrete-Time Signals and Systems 510
Streptostylie bei Dinosauriern nebst Bemerkungen über die 500
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5908187
求助须知:如何正确求助?哪些是违规求助? 6802932
关于积分的说明 15769324
捐赠科研通 5032256
什么是DOI,文献DOI怎么找? 2709473
邀请新用户注册赠送积分活动 1659085
关于科研通互助平台的介绍 1602894